United States · FDA National Drug Code directory
SILODOSIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-095_ba067fa8-8f09-40fb-be9d-a9ff2b0fd72d
- Product NDC
- 59651-095
- Form
- CAPSULE
- Composition / generic term
- SILODOSIN
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181210
- Source listing expiry
- 20261231
Source-listed ingredients
- SILODOSIN — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (59651-095-30) · 59651-095-30
- 90 CAPSULE in 1 BOTTLE (59651-095-90) · 59651-095-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →